<SEC-DOCUMENT>0001264931-21-000078.txt : 20210617
<SEC-HEADER>0001264931-21-000078.hdr.sgml : 20210617
<ACCEPTANCE-DATETIME>20210617093724
ACCESSION NUMBER:		0001264931-21-000078
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210617
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210617
DATE AS OF CHANGE:		20210617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jupiter Wellness, Inc.
		CENTRAL INDEX KEY:			0001760903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				832455880
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39569
		FILM NUMBER:		211023552

	BUSINESS ADDRESS:	
		STREET 1:		725 N. HWY A1A
		STREET 2:		SUITE C-106
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33458
		BUSINESS PHONE:		561-325-0482

	MAIL ADDRESS:	
		STREET 1:		725 N. HWY A1A
		STREET 2:		SUITE C-106
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33458

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CBD Brands, Inc.
		DATE OF NAME CHANGE:	20181206
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>jupw8k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:JUPW="http://jupiterwellness.com/20210616">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_JUPW_jupiterwellness.com_20210616 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20210617_20210617 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001760903 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityEmergingGrowthCompany_true -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityExTransitionPeriod_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-06-17to2021-06-17" name="dei:EntityCentralIndexKey">0001760903</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-17to2021-06-17" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-17to2021-06-17" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-17to2021-06-17" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0024" name="dei:WrittenCommunications">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0025" name="dei:SolicitingMaterial">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0026" name="dei:PreCommencementTenderOffer">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0027" name="dei:PreCommencementIssuerTenderOffer">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="jupw-20210616.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-06-17to2021-06-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-17</xbrli:startDate>
        <xbrli:endDate>2021-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-162021-06-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-16</xbrli:startDate>
        <xbrli:endDate>2021-06-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-162021-06-16_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-16</xbrli:startDate>
        <xbrli:endDate>2021-06-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-162021-06-16_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">JUPW:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-16</xbrli:startDate>
        <xbrli:endDate>2021-06-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20210617__20210617_zpQh2PHxaYgi"><ix:nonNumeric contextRef="From2021-06-17to2021-06-17" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported): <span id="xdx_90A_edei--DocumentPeriodEndDate_c20210617__20210617_zPOWs9etTgY"><ix:nonNumeric contextRef="From2021-06-17to2021-06-17" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June
17, 2021</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_901_edei--EntityRegistrantName_c20210617__20210617_zcqirZQkepm9"><ix:nonNumeric contextRef="From2021-06-17to2021-06-17" name="dei:EntityRegistrantName">JUPITER WELLNESS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20210616__20210616_zkZ4GNEcmWMd"><ix:nonNumeric contextRef="From2021-06-162021-06-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityFileNumber_c20210616__20210616_zu6zVnKav6y6"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityFileNumber">001-39569</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20210616__20210616_zakX0wN8agxk"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityTaxIdentificationNumber">83-2455880</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20210616__20210616_zMb1A0AmgaLh"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityAddressAddressLine1">725 N. Hwy A1A</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressCityOrTown_c20210616__20210616_zCS4nROyKPia"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityAddressCityOrTown">Suite C-106 Jupiter</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20210616__20210616_zv8D4yq2eXX5"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20210616__20210616_zzavRYQLRanl"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityAddressPostalZipCode">33477</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_903_edei--CityAreaCode_c20210616__20210616_zFbitTo5LTE2"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:CityAreaCode">(561)</ix:nonNumeric></span> <span id="xdx_90C_edei--LocalPhoneNumber_c20210616__20210616_zLO8LvmRea92"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:LocalPhoneNumber">244-7100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&#8217;s telephone number, including area
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_909_edei--EntityInformationFormerLegalOrRegisteredName_c20210616__20210616_zzowyZhFlY46"><ix:nonNumeric contextRef="From2021-06-162021-06-16" name="dei:EntityInformationFormerLegalOrRegisteredName">Not Applicable</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since last
report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span> General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--WrittenCommunications_c20210616__20210616_zwSpq0nj7b3k"><span style="-sec-ix-hidden: xdx2ixbrl0024">[&#160;&#160;]</span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--SolicitingMaterial_c20210616__20210616_zJADLdLLx8wa"><span style="-sec-ix-hidden: xdx2ixbrl0025">[&#160;&#160;]</span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--PreCommencementTenderOffer_c20210616__20210616_zJJsV3bfixk1"><span style="-sec-ix-hidden: xdx2ixbrl0026">[&#160;&#160;]</span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20210616__20210616_zms5hW3jcszb"><span style="-sec-ix-hidden: xdx2ixbrl0027">[&#160;&#160;]</span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities registered pursuant to Section 12(b) of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 31%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of each exchange on which registered </b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"><span id="xdx_904_edei--Security12bTitle_c20210616__20210616__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zukNAuAmxLg7"><ix:nonNumeric contextRef="From2021-06-162021-06-16_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"><span id="xdx_903_edei--TradingSymbol_c20210616__20210616__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zd6fwZSdThl9"><ix:nonNumeric contextRef="From2021-06-162021-06-16_us-gaap_CommonStockMember" name="dei:TradingSymbol">JUPW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: #CCEEFF"><span style="background-color: #CCEEFF"><span id="xdx_904_edei--SecurityExchangeName_c20210616__20210616__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_z2Ylz1PesWOd"><ix:nonNumeric contextRef="From2021-06-162021-06-16_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: #CCEEFF"><span style="background-color: #CCEEFF">(The
    Nasdaq Capital Market)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: #CCEEFF">&#160;</p></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"><span id="xdx_90C_edei--Security12bTitle_c20210616__20210616__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zuIa6M58Rw4f"><ix:nonNumeric contextRef="From2021-06-162021-06-16_custom_WarrantsMember" name="dei:Security12bTitle">Warrants,</ix:nonNumeric></span> </span><span style="font: 10pt Times New Roman, Times, Serif">each exercisable for one share of Common Stock at $8.50 per share</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"><span id="xdx_903_edei--TradingSymbol_c20210616__20210616__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zAtnYh9WcFmd"><ix:nonNumeric contextRef="From2021-06-162021-06-16_custom_WarrantsMember" name="dei:TradingSymbol">JUPWW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: #CCEEFF"><span style="background-color: #CCEEFF"><span id="xdx_902_edei--SecurityExchangeName_c20210616__20210616__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_z2LkPdyDpnfh"><ix:nonNumeric contextRef="From2021-06-162021-06-16_custom_WarrantsMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: #CCEEFF"><span style="background-color: #CCEEFF">(The
    Nasdaq Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Emerging growth company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20210617__20210617_z0S4lYrforcb"><ix:nonNumeric contextRef="From2021-06-17to2021-06-17" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">[X]</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 1.01. Material Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 16, 2021, Jupiter Wellness, Inc. (the &#34;Company&#34;)
entered into a license agreement (the &#34;License Agreement&#34;) with the Oklahoma Medical Research Foundation (&#34;OMRF&#34;),
covering the Company's use of OMRF's Patents US 6,156,795 and US 6,326,400, relating to the treatment of contact dermatitis with N-L-Alpha-Aspartyl-L-Phenylalanine-1-Methyl
Ester, otherwise known as the artificial sweetener aspartame. Under the License Agreement, the Company has gained the worldwide exclusive
license to utilize the Patent Rights, Know-How and Material related to N-L-Alpha-Aspartyl-L-Phenylalanine-1-Methyl Ester in order to make,
use, distribute, sublicense and sell Licensed Products or Licensed Services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The License Agreement became effective on June 16,
2021, and will end upon the expiration of the last of the</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Company's Valid Claims within the Patent Rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company agreed to issue OMRF $375,000-worth of
the Company's common stock as an initial payment (the &#8220;OMRF Shares&#8221;), relying on an exemption from the registration requirements
of the Securities Act of 1933, as amended (the &#8220;Act&#8221;), pursuant to Section 4(2) of the Act and/or Regulation D promulgated
thereunder. Upon its achievement of annual worldwide net sales of $10,000,000 of the first Licensed Product, the Company will pay OMRF
an additional $1,000,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The License Agreement helps forward the Company's
research into the possible applications of CBD/aspartame mixtures in treating a variety of skin conditions, including atopic dermatitis
(eczema), as described in patent filing US 20210038513.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 3.02. Unregistered Sales of Equity Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information under Item 1.01 is incorporated by
reference into this Item 3.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 7.01. Regulation FD Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 16, 2021, the Company issued a press release
announcing the License Agreement (the &#8220;Press Release&#8221;). A copy of the press release is furnished hereto as <span style="text-decoration: underline">Exhibit 99.1</span>
and incorporated herein by reference.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1F497D">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 10%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit&#160;No.</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 89%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">10.1</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">99.1</p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><a href="ex10_1.htm">License Agreement, dated June 16, 2021</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><a href="ex99_1.htm">Press release, dated June 17, 2021</a></p></td></tr>
  </table>
<p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>

<p style="font: 10pt/106% Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 8pt">&#160;<b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: June 17, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><b>JUPITER WELLNESS, INC.</b></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="width: 53%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 46%"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/ Brian John</i></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Brian John</i></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1j0FOwzAQRU+QO4y8jto4IghlBxGtECmqQgVsTTKtrMaeaOwWeiRuieMQsQHLkjXz/5vvESIVa1rpHhne7poadmiGXnmEBvfIaFsMjurhsYTwNnjQzrOyPpYzWFFgMDDF4kaFfnSetcOuhOx6KYtlLiEryisJ241IRr0iu9cdWq9VD8p2sGUaWKNXfJkm7NQnWTKXmPSC7DTZEuQim+QvyDOZwxOd1Qfx0UFdVyJJ40nEmuk0jDEn58nAfY8mZLkJ/b3xK230lK+Kx8XcBs07cujLLA8Rtz95s5z+gYb9DdlnT+3xH3pyQLTMA74BOGVsUQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10_1.htm
<DESCRIPTION>LICENSE AGREEMENT, DATED JUNE 16, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0.05in; margin-bottom: 0; margin-left: 0; text-align: right">Exhibit 10.1</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0.05in 106.05pt 0 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0.05in 106.05pt 0 0; text-align: center; text-indent: 0.5in">LICENSE
AGREEMENT</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0.05in 106.05pt 0 0; text-align: center; text-indent: 0.5in">BETWEEN</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0.05in 106.05pt 0 0; text-align: center; text-indent: 0.5in">OKLAHOMA
MEDICAL RESEARCH FOUNDATION</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0.05in 106.05pt 0 0; text-align: center; text-indent: 0.5in">AND</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0.05in 106.05pt 0 0; text-align: center; text-indent: 0.5in">JUPITER
WELLNESS INC.</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0.5in">This License Agreement
(&ldquo;Agreement&rdquo;) is by and between Oklahoma Medical Research Foundation, located at 825 NE 13th Street, Oklahoma City, OK 73104
(&ldquo;OMRF&rdquo;), and Jupiter Wellness Inc. having a place of business at <FONT STYLE="background-color: white">725 North Hwy A1A,
Suite C106 Jupiter, FL 33477(&ldquo;Company&rdquo;)</FONT>, each a &ldquo;Party,&rdquo; and collectively &ldquo;Parties&rdquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0.5in">WHEREAS, OMRF owns
rights in and to the technology relating to various uses of N-L-Alpha-Aspartyl-L-Phenylalanine-1-Methyl Ester, which is further defined
below;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0.5in">WHEREAS, COMPANY
desires to obtain the right to utilize the Patent Rights, Know-How and Material related to N-L-Alpha-Aspartyl-L-Phenylalanine-1-Methyl
Ester in order to make, use, distribute, sublicense and sell Licensed Products (as defined below).&nbsp;</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0.5in">NOW THEREFORE,
in consideration of the foregoing and the terms and conditions set forth below, the Parties hereby agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 12pt Times New Roman, Times, Serif">Article 1.00 &ndash; Definitions<B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 6pt">For purposes of this Agreement, the terms defined in this
Article will have the meaning specified and will be applicable both to the singular and plural forms:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 6pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 6pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>1.01</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Affiliate&rdquo; </B>of a party shall mean: any entity that, directly or indirectly, through one or more intermediaries,
    controls, is controlled by, or is under common control with, such party. For purposes of this definition, &ldquo;control&rdquo; will
    mean the direct or indirect ownership of (a) at least fifty per cent (50%) or the maximum percentage, if less than fifty per cent
    (50 %), as allowed by applicable law, of the outstanding voting securities of such entity, or (b) at least fifty per cent (50%) of
    the decision-making authority of such entity.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.02</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Confidential Information&rdquo;</B><FONT STYLE="font-size: 12pt">: All proprietary unpublished
    or nonpublic information or materials including, but not limited to, written, oral or virtually presented information and such items
    as electronic media products, trade secrets, financial information, equipment, databases and the like provided by one Party to the
    other under this Agreement, or which is observed by a Party while on the other Party&rsquo;s premises. Confidential Information does
    not include any information or material that receiving party evidences is: (a) already known to the receiving party at the time of
    disclosure (other than from the disclosing party); (b) publicly known other than through acts or omissions of the receiving party;
    (c) disclosed to the receiving party by a third party who was not and is not under any obligation of confidentiality; or (d) independently
    developed by employees of the receiving party without knowledge of or access to the Confidential Information.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.03</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Effective
Date&rdquo;</B>: June 16, 2021.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.04</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Field&rdquo;</B>:&nbsp;means
all uses of the Patent Rights.&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 6pt">&nbsp;</P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 40.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 40.5pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>1.05</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Know-How&rdquo;</B>:
research and development information, materials, technical data, unpatented inventions, trade secrets, know-how and supportive information
generated by OMRF, which is owned and controlled by OMRF as of the Effective Date and provided for the development, use or manufacture
of a Licensed Product.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.06</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Licensed
Product&rdquo;</B>: any product or process, including, but not limited to Improvements: covered by a pending claim directed to an invention
in the Patent Rights; (b) the manufacture, use, sale, offer for sale or importation of which infringes an issued claim of the Patent Rights,
or that would infringe but for the exception in 35 U.S.C. &sect;271(e)(1), or similar exception in the United States or other countries;
or (c) the development, manufacture, use, sale, offer for sale or importation of which incorporates, uses, validated or was directly derived
from, in whole or in part using the Know-How or Materials.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>&nbsp;1.10</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Licensor&rdquo;</B>:&nbsp;OMRF.&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>&nbsp;1.11</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Materials&rdquo;:
</B>Biological specimens, algorithms, software, documentation, data or other tangible property provided by OMRF to COMPANY during the
Term, or used by OMRF during the Term, to generate data that supports the development of Licensed Product.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.12</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Net
Sales&rdquo;</B>: The amount invoiced by COMPANY or its Affiliates, or sublicensees, for the sale or transfer of a Licensed Product to
a third party, less documented: (a) sales, excise or use taxes shown on the face of the invoice; (b) credits for defective or returned
Licensed Products actually given; and (c) regular trade and discount allowances given. Leasing, lending, consigning or any other activity
by means of which a non-Affiliated third party acquires the right to possess or use a Licensed Product shall be deemed a transfer for
the purpose of determining Net Sales. Net Sales on Licensed Products transferred as part of a non-cash exchange shall be calculated at
the then-current customary sales price invoiced to third parties. In the event that COMPANY transfers Licensed Products to an Affiliate,
and the Affiliate retransfers the Licensed Products to third-party customers, then Net Sales shall be the price charged by the Affiliate
to third-party customers, less documented allowable deductions taken. If such Affiliate does not retransfer the Licensed Product to third-party
customers within one year, Net Sales shall be calculated to be the higher of:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(a)</TD>
    <TD STYLE="text-align: justify">the price charged by the Licensee to the Affiliate, or</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(b)</TD>
    <TD STYLE="text-align: justify">average price charged by the licensee to third-party customers,  or</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(c)</TD>
    <TD STYLE="text-align: justify">in the absence of sales to third party customers,
the fair market price for the Licensed Products.</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 40.5pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 6pt; text-align: justify">Net Sales accrues with the first of delivery
or invoice is paid.&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 6pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>1.13</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Patent
Rights&rdquo;</B>: (a) US issued patent numbered 7,288,527, Title: &rdquo;<I>Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine
1-methyl ester</I>&rdquo; which issued on 10/30/2007 and that is solely owned by OMRF, (b) US issued patent numbered 7,816,327, Title:
&ldquo;<I>Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester</I>&rdquo; issued on 10/19/2010
and that is solely owned by OMRF, and (c) patents derived therefrom, patents issuing thereon, continuation, divisional, continuation-in-part
patents (but only for subject matter supported pursuant to 35 U.S.C. &sect;112 by the foregoing), re-examinations and re-issues thereof,
as well as extensions and supplementary protection certificates and any foreign counterpart of any of the foregoing.</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 6pt; text-align: justify"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.75pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.75pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>1.14</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Sublicensee&rdquo;:
</B>any third party to whom COMPANY has conveyed rights or the forbearance of suit under the Patent Rights, Know-How or Materials.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.15</B></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt"><B>&ldquo;Term&rdquo;</B>:
begins on the Effective Date and ends, subject to Article 10, upon the happening of the latter of the following events: (1) the last to
expire Valid Claim within the Patent Rights, or</FONT> (2) ten (10) years after first commercial sale of a Licensed Product.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.16</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Territory&rdquo;</B>:
worldwide&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>1.17</B></TD>
    <TD STYLE="text-align: justify"><B>&ldquo;Valid
Claim&rdquo;:</B> &ldquo;Valid Claim&rdquo; shall mean a pending, issued or otherwise unexpired claim within the Patent Rights that has
not been held invalid or unenforceable by an un-appealable decision of a court or agency of competent jurisdiction.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.75pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 2.00 - Grant of Rights&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>2.01</B></TD>
    <TD STYLE="text-align: justify"><B>GRANT.
</B>Subject to the terms and conditions of this Agreement, OMRF grants to COMPANY: (a) an exclusive license with the right to sublicense,
with OMRF&rsquo;s prior written consent, which OMRF shall not unreasonably withhold, within the Field and Territory, under the Patent
Rights to make, have made, use, have used, offer for sale, sell, have sold, and import and have imported, Licensed Products; and (b) a
nonexclusive license, with the right to sublicense with OMRF&rsquo;s prior written consent, which OMRF shall not unreasonably withhold,
within the Field and Territory, to use the Know-How and Materials to develop, make, have made, use, have used, offer for sale, sell, have
sold, and import and have imported, Licensed Products. COMPANY shall provide reasonably detailed notice in writing to OMRF of any intended
sublicense and, within five (5) business days after receipt of such notice, OMRF will advise COMPANY in writing whether OMRF accepts such
proposed sublicense and, if not, the reasons therefor. Failure of OMRF to give such notice will be deemed consent by OMRF to such sublicense.
The Parties understand and acknowledge that OMRF will only object to sublicenses under this paragraph in extraordinary circumstances,
which may include sublicenses with parties who are (i) in material default under any material obligation to OMRF, or in litigation or
other dispute with OMRF, or (ii) engaging in significant activities in conflict with the stated mission of OMRF.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>2.02</B></TD>
    <TD STYLE="text-align: justify"><B>RESERVATION
OF RIGHTS</B>. Notwithstanding any of the terms in this Agreement, all rights herein are subject to: (a) the rights and obligations to
and requirements of the U.S. government, if any have arisen or may arise, regarding the Patent Rights, including as set forth in 35 U.S.C.
&sect;&sect;200 et al., 37 C.F.R. Part 401 et al. (&ldquo;Bayh-Dole Act&rdquo;); and (b) OMRF retain the right, on behalf of themselves
and their Affiliates, to practice the Patent Rights and use the technology for any non-profit purpose, including sponsored research and
collaborations.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>2.03</B></TD>
    <TD STYLE="text-align: justify"><B>NO
OTHER RIGHTS GRANTED. </B>This Agreement does not grant any right, title or interest in or to any tangible or intangible property right
of OMRF or its Affiliates, including any improvements thereon, or to any patents, know-how or materials that is not expressly stated in
Section 2.01. All such rights, titles and interests are expressly reserved by OMRF and COMPANY agrees that in no event will this Agreement
be construed as a sale, an assignment or an implied license by OMRF or its Affiliates to COMPANY of any such rights.</TD></TR>
  </TABLE>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>2.04</B></TD>
    <TD STYLE="text-align: justify"><B>SUBLICENSES.
</B>Any sublicense by COMPANY shall be to a Sublicensee that agrees in writing to be bound by substantially the same terms and conditions
as COMPANY herein, including, but not limited to, relevant/applicable financial terms and conditions, or such sublicense shall be null
and void, and no grant by COMPANY of any sublicense shall relieve COMPANY of any obligation of COMPANY under this Agreement. Sublicenses
granted hereunder shall not be transferable, including by further sublicensing, delegatable or assignable without the prior written approval
of OMRF, which approval shall not be unreasonably withheld, or such further sublicensing, delegation or assignation shall be null and
void. COMPANY will provide OMRF with a copy of each sublicense agreement promptly after execution. COMPANY is responsible for the payment
of any payments provided for hereunder triggered by such Sublicense, regardless of whether the terms of any sublicense require that Sublicensee
pay such amounts (such as in a fully paid-up license) to COMPANY or that such amounts be paid by the Sublicensee directly to OMRF. Each
sublicense agreement shall name OMRF as a third party beneficiary and, unless OMRF has provided written consent, all rights of Sublicensees
shall terminate when COMPANY&rsquo;s rights terminate. COMPANY shall not grant any fully-paid up, royalty-free or exclusive sublicenses
without OMRF&rsquo;s prior written consent.&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 3.00 - Royalties&nbsp;</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>3.01</B></TD>
    <TD STYLE="text-align: justify"><B>UP-FRONT
PAYMENT. </B>COMPANY, COMPANY will make a nonrefundable and non-creditable up-front payment in COMPANY&rsquo;s common stock to OMRF in
the amount of Three Hundred Seventy Five Thousand US Dollars ($375,000). The price per share of COMPANY&rsquo;S common stock will be the
closing market price of the Effective Date of this Agreement.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>3.02</B></TD>
    <TD STYLE="text-align: justify"><B>MILESTONE
FEES. </B>COMPANY, its Affiliates and Sublicensees will pay the following nonrefundable and noncreditable milestone fees to OMRF for the
first Licensed Product developed by COMPANY upon the every achievement of the following events:</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; border: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 69%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6.85pt; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">E</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9.5pt">VENT</FONT></TD>
    <TD STYLE="width: 26%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 0.1pt; padding-right: 20.1pt; padding-left: 25.8pt; line-height: 13.8pt; text-indent: -4.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">M</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9.5pt">ILESTONE </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">P</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9.5pt">AYMENT</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6.75pt; padding-left: 0.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">1</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 0.05pt; padding-right: 4.4pt; padding-left: 5.35pt; line-height: 13.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Achievement of annual worldwide Net Sales of $10 Million of the first Licensed Product.</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6.75pt; padding-left: 5.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">$US 1,000,000</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0.4pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;<FONT STYLE="font-size: 12pt; letter-spacing: -0.2pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>3.03</B></TD>
    <TD STYLE="text-align: justify"><B>SUBLICENSE
INCOME ROYALTY. </B>COMPANY will make nonrefundable and non- creditable payments to OMRF of the following Sublicense Income.&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(a)</TD>
    <TD STYLE="text-align: justify">Twenty
percent (20%) of all consideration received by COMPANY for any sublicense entered into by COMPANY.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(b)</TD>
    <TD STYLE="text-align: justify"><P STYLE="text-align: justify"><B>TAXES. </B>COMPANY is responsible for all taxes, duties, import
duties, assessments and other governmental charges, however designated, which are now or hereafter imposed by any authority on COMPANY:
(a) by reason of the performance by OMRF of its obligations under this Agreement;&nbsp;based on the Patent Rights; or (c) related to
use, sale or importation of the Licensed Product. Any withholding taxes that COMPANY is required by law to withhold on remittance of
the royalty payments shall be withheld from the royalties due under this Agreement. However, COMPANY will obtain, or assist OMRF in obtaining,
any tax reduction (including avoidance of double taxation), tax refund or tax exemption available to OMRF by treaty otherwise.</P>
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>3.10</B></TD>
    <TD STYLE="text-align: justify"><B>U.S.
CURRENCY. </B>All payments made to OMRF under this Agreement will be made by draft drawn on a U.S. bank, and payable in U.S. dollars unless
otherwise agreed upon in writing by the Parties. In the event that conversion from foreign currency is required in calculating a payment
under this Agreement, the exchange rate used shall be the Interbank rate quoted by US Bank at the end of the last business day of the
quarter in which the payment accrued.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.2pt"></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt; letter-spacing: -0.2pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>3.11</B></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; letter-spacing: -1.5pt"><B>&nbsp;
</B></FONT><B><FONT STYLE="font-size: 12pt">OVERDUE PAYMENTS. </FONT></B><FONT STYLE="font-size: 12pt">If overdue, the payments due under
this Agreement shall bear interest until paid at a per annum rate of two percent (2%) above the prime rate in effect at US Bank on the
due date. OMRF shall be entitled to recover, in addition to all other remedies, reasonable attorneys&rsquo; fees and costs related to
the administration or enforcement of this Agreement, including collection of payments, following COMPANY&rsquo;s such failure to pay.
The acceptance of any payment, including such interest, shall not foreclose OMRF from exercising any other right or seeking any other
remedy that it may have as a consequence of the failure of COMPANY to make any payment when due. </FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="text-align: center; font: bold 12pt Times New Roman, Times, Serif">Article 4.00 - Accounting and Reports&nbsp;</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>4.01</B></TD>
    <TD STYLE="text-align: justify"><B>REPORTS
AND PAYMENT. </B>COMPANY will deliver to OMRF on or before the following dates: 1 February and 1 August, a written report setting forth
a full accounting showing how any amounts due to OMRF for the preceding calendar half-year have been calculated as provided in this Agreement,
including an accounting of total Net Sales with a reporting of applicable foreign exchange rates, deductions, allowances, and charges
and any payments due from Sublicensees. Each report will include product names and quantity sold for each country in which the Licensed
Product was sold. Furthermore, the report will include detailed information about Licensed Products sold to OMRF or OMRF Affiliates. If
no Licensed Product transfers have occurred and no other amounts are due to OMRF, COMPANY will submit a report so stating. Each such report
will be accompanied by the payment of all amounts due for such calendar half- year.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>4.02</B></TD>
    <TD STYLE="text-align: justify"><B>ACCOUNTING.</B>
COMPANY will, throughout the Term, keep complete, continuous, true and accurate books of accounts and records sufficient to support and
verify the calculation of Net Sales, all royalties and any other amount believed due and payable to OMRF under this Agreement. Such books
and records will be open at all reasonable times but no more often than once per calendar quarter for inspection by a representative of
OMRF for audit and verification of royalty statements or of compliance with other aspects of this Agreement. The OMRF representative will
treat as confidential all relevant matters and will be a person or firm reasonably acceptable to COMPANY. In the event such audit reveals
an underpayment by COMPANY, COMPANY will within thirty (30) days pay the royalty due in excess of the royalty actually paid. In the event
the audit reveals an underpayment by COMPANY of more than three percent (3%) of the amount due, COMPANY will pay all of OMRF&rsquo;s costs
in conducting the audit and an interest on the royalty due in excess of the royalty actually paid at the highest rate then permitted by
law.</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 5.00 - Diligence&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>5.01</B></TD>
    <TD STYLE="text-align: justify"><B>DILIGENCE
REPORTS. </B>COMPANY will provide OMRF with annual reports within thirty (30) days of each anniversary of the Effective Date describing
in detail: (a) as of that reporting period, all development and marketing activities for each Licensed Product and the names of all Sublicensees
(if any), including which of the Sublicensees are Affiliates; and (b) an updated development plan for the next annual period. OMRF shall
have the right to audit COMPANY&rsquo;s and Sublicensees&rsquo; records relating to development of Licensed Products.</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 6.00 &ndash; Intellectual Property Management</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><B>6.01</B></TD>
    <TD STYLE="text-align: justify"><B>CONTROL. </B>OMRF will confer with COMPANY to
develop a strategy for the prosecution and maintenance of Patent Rights. OMRF will have the sole right to prepare, file, prosecute, maintain,
abandon, or otherwise handle the Patent Rights in consultation with the COMPANY using the services of a patent counsel reasonably acceptable
to COMPANY and at COMPANY&rsquo;s expense. OMRF, through its patent counsel, will keep COMPANY informed of the patent related activities.
OMRF shall make available to COMPANY the serial numbers and filing dates, together with copies of all the applications, including copies
of all patent office actions from any patent office, responses and all other communications from any patent office. OMRF will accept any
reasonable advice and guidance provided by COMPANY regarding patent prosecution strategy and/or drafting of any related documents. COMPANY
shall reimburse OMRF during the Term for all documented costs and expenses associated with the Patent Rights incurred by OMRF on or after
the Effective Date within thirty (30) days of invoice. Neither Party will be liable to the other for any act or omission in the preparation,
filing, prosecution, maintenance, abandonment, enforcement, defense or other handling of the Patent Rights. In addition, OMRF shall promptly
advise COMPANY of the grant, lapse, revocation, surrender, of any threatened invalidation or of its intention to abandon any such patent,
application or foreign counterpart.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>6.02</B></TD>
    <TD STYLE="text-align: justify"><B>ENFORCEMENT.
</B>Each Party shall inform the other in writing of any suspected infringement of any Patent Rights, and OMRF and COMPANY will have the
following right to institute an action for infringement of the Patent Rights</TD></TR>
</TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 4.9pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.5pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">COMPANY shall have the first right, but not the
obligation, to institute a suit for infringement of any Patent Rights. If COMPANY elects to commence such an action, COMPANY shall bear
all expenses related to such action and, OMRF at its option, may join as a Party to such action. If Parties agree to institute suit jointly,
then the suit will be brought in the names of both Parties. COMPANY will exercise control over such action, provided, however, that OMRF
may, if it so desires, be represented by counsel of its own selection. Regardless of whether OMRF joints as a Party, COMPANY shall control
such action, and OMRF shall, within reason and at COMPANY&rsquo;s sole expense, cooperate with COMPANY (except financially) in connection
with any such action. COMPANY will indemnify OMRF and its Affiliates, including the trustees, officers, agents, and employees of the foregoing,
in respect to any damages or other costs of any type arising out of or relating to such enforcement. OMRF shall not be required to join
such action unless it has agreed to do so in writing prior to the commencement thereof, or unless deemed by the court as a necessary party.
Recoveries or reimbursements from infringement actions commenced by COMPANY shall be distributed as follows: (i) the Parties shall be
fully reimbursed for documented litigation expenses, including but not limited to reasonable attorneys&rsquo; fees; (ii) as to ordinary
damages, COMPANY shall receive an amount equal to its lost profits or a reasonable royalty on the sales of the infringer (whichever measure
of damages the court shall have applied); and (iii) any remaining recoveries or reimbursements shall be paid seventy percent (70%) to
COMPANY and thirty percent (30%) to OMRF. COMPANY will not settle or enter into a voluntary disposition of the action without OMRF&rsquo;s
prior written consent, which consent shall not be unreasonably withheld.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.5pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">In the absence of an agreement to institute a suit
jointly, and if COMPANY determines not to institute a suit in a reasonable time after learning about a suspected infringement of Patent
Rights, then OMRF may at its sole discretion institute suit. COMPANY shall not be required to join such action unless it has agreed to
do so in writing prior to the commencement thereof, or unless deemed by the court as a necessary party. OMRF will bear the entire cost
of such litigation, including attorneys' fees. COMPANY will cooperate reasonably with the OMRF, except financially, in such litigation
and OMRF will indemnify COMPANY and its Affiliates, including the trustees, officers, agents, and employees of the foregoing, in respect
to any damages or other costs of any type arising out of or relating to such enforcement. Regardless of whether COMPANY joints as a Party,
OMRF shall control such action and recoveries or reimbursements from such infringement actions commenced by OMRF shall be distributed
as follows: (i) the Parties shall be fully reimbursed for documented litigation expenses, including but not limited to reasonable attorneys&rsquo;
fees; (ii) and all remaining recoveries or reimbursements shall be paid seventy percent (70%) to OMRF and thirty percent (30%) to COMPANY.
OMRF will not settle or enter into a voluntary disposition of the action without COMPANY&rsquo;s prior written consent, which consent
shall not be unreasonably withheld.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.5pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">If either Party institutes a suit under this Section
6.02 and then decides to abandon the suit, it will first provide timely written notice to the other Party of its intention to abandon
the suit, and the other Party, if it wishes, may continue prosecution of such suit, provided, however, that the sharing of expenses and
of any recovery in such suit will be agreed-upon separately by the Parties.</FONT></TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 39pt"><FONT STYLE="letter-spacing: -0.95pt"><B>6.03
</B></FONT></TD>
    <TD STYLE="text-align: justify"><B>PATENT
TERM EXTENSION</B>. OMRF will, in consultation with COMPANY, select the patent covering each Licensed Product for patent term extension
for or supplementary protection certificate under in accordance with the applicable laws of any country. Each Party agrees to execute
any documents and to take any additional actions as the other Party may reasonably request in connection therewith.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="letter-spacing: -0.95pt"><B>6.04
</B></FONT></TD>
    <TD STYLE="text-align: justify"><B>PATENT
MARKING. </B>To the extent commercially feasible, COMPANY will mark all Licensed Products that are manufactured or sold under this Agreement
with the number of each issued patent within the Patent Rights that cover such Licensed Product(s). Any such marking will be in conformance
with the patent laws and other laws of the country of manufacture or sale.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="letter-spacing: -0.95pt"><B>6.05
</B></FONT></TD>
    <TD STYLE="text-align: justify"><B>DEFENSE</B>.
OMRF shall take reasonable measure regarding (a) challenges to the Patent Rights (including interferences in the U.S. Patent and Trademark
Office and oppositions in foreign jurisdictions) and (b) defense of the Patent Rights (including declaratory judgment actions). COMPANY
shall reasonably cooperate in any such measures if requested to do so by OMRF.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>6.06</B></TD>
    <TD STYLE="text-align: justify"><P><B>THIRD PARTY LITIGATION.</B> In the event a third party institutes a suit against COMPANY for
                                    infringement involving a Licensed Product, COMPANY will promptly inform OMRF and keep OMRF regularly
                                    informed of the proceedings. COMPANY agrees to indemnify, defend and hold harmless OMRF for any claims,
                                    demands or lawsuits related thereto.</P>
</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 7.00 &ndash; Use of Name</P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt">COMPANY will not use for publicity, promotion or otherwise,
any logo, name, trade name, service mark or trademark of OMRF or its Affiliates, or any simulation, abbreviation or adaptation
of the same, or the name of any employee or agent of OMRF without OMRF&rsquo;s individual prior, written, express consent. Similarly.
OMRF will not use for publicity, promotion or otherwise, any logo, name, trade name, service mark or trademark of COMPANY or its
Affiliates, or any simulation, abbreviation or adaptation of the same, or the name of any employee or agent of the COMPANY, without COMPANY&rsquo;s
prior, written, express consent.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 6pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 6pt">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 8.00 - Confidentiality&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><B>8.01</B></TD><TD STYLE="text-align: justify"><B>TREATMENT
OF CONFIDENTIAL INFORMATION</B>. Except as provided for in Section 8.02, neither Party will disclose, use or otherwise make available
the other&rsquo;s Confidential Information during the Term and for five (5) years thereafter and will use the same degree of care it employs
to protect its own confidential information.</TD></TR>
                                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                           <TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><B>8.02</B></TD><TD STYLE="text-align: justify"><B>RIGHT TO DISCLOSE.</B></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">To the extent it is reasonably necessary or appropriate
to fulfill its obligations or exercise its rights under this Agreement, COMPANY may disclose Confidential Information of OMRF to its Sublicensees,
consultants, and outside contractors on the condition that each such entity agrees to obligations of confidentiality and non- use at least
as stringent as those therein.</FONT></TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">To the extent it is reasonably necessary or appropriate
to fulfill its obligations or exercise its rights under this Agreement, OMRF may disclose Confidential Information of COMPANY to its consultants
and outside contractors on the condition that each such entity agrees to obligations of confidentiality and non-use at least as stringent
as those therein.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">If a Party is required by law, regulation or court
order to disclose any of the Confidential Information, it will have the right to do so, provided it: (i) promptly notifies the disclosing
party; and (ii) reasonably assists the disclosing party to obtain a protective order or other remedy of disclosing party&rsquo;s election
and at disclosing party&rsquo;s expense, and only disclose the minimum amount necessary to satisfy such obligation.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>8.03
</B></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt"><B>CONFIDENTIALITY
OF AGREEMENTS. </B>Except as otherwise required by law, the specific terms and conditions of this Agreement shall be Confidential Information
but the existence and Field of this Agreement will not be Confidential Information and the Parties may state that COMPANY is licensed
under the Patent Rights. OMRF may, however, disclose the terms and conditions of this Agreement to their board of Governors, board of
directors, committees thereof,</FONT>and its conflicts of interest committees.</TD></TR>
  </TABLE>

<P STYLE="text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 4.9pt; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 4.9pt; margin-bottom: 0; margin-left: 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 9.00 &ndash; Warranties, Representations, Disclaimers
and Indemnification</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -0.05pt"><B>9.01</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt"><B>MUTUAL REPRESENTATIONS AND WARRANTIES.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">Each Party represents and warrants to the other
that the execution and delivery of this Agreement has been duly authorized and no further approval, corporate or otherwise, is required
in order to execute this binding Agreement; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">Each Party represents and warrants to the other that
it shall comply, and COMPANY shall require its Sublicensees to comply, with any applicable international, national and state laws, ordinances
and regulations in its performance under this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">OMRF represents and warrants to the COMPANY that
to its knowledge, it has the right to enter into this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">OMRF warrants that it owns the Patent Rights, Know-How
and Material related to N-L-Alpha-Aspartyl-L-Phenylalanine-1-Methyl Ester.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 39pt"><FONT STYLE="letter-spacing: -0.05pt">9.02</FONT></TD><TD>ADDITIONAL REPRESENTATIONS AND WARRANTIES OF COMPANY.</TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 6pt">COMPANY represents and warrants to OMRF that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">it is experienced in the development, production,
quality control, service, manufacture, marketing and sales of products similar to the subject matter of the Patent Rights, and that it
will commit itself to a thorough, vigorous and diligent program of developing and marketing the Licensed Products;</FONT></TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">it has independently evaluated the Patent Rights,
Know-How and Materials and Confidential Information, if any, their applicability or utility in COMPANY&rsquo;s activities, is entering
into this Agreement on the basis of its own evaluation and not in reliance of any representation by OMRF, and assumes all risk and liability
in connection with such determination;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">it now maintain throughout the Term and beyond insurance
coverage as set forth in Section 9.04 and that such insurance coverage sufficiently covers the OMRF Indemnitees; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">its rights and obligations under this Agreement
do not conflict with any contractual obligation or court or administrative order by which it is bound.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 78pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 78pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 78pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 78pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0.45pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt">9.03</FONT></TD><TD>DISCLAIMERS.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(a)</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">Except
as expressly stated in Section 9.01 or 9.02, OMRF AND COMPANY HAVE NOT MADE AND DO NOT MAKE ANY PROMISES, COVENANTS, GUARANTEES, REPRESENTATIONS
OR WARRANTIES OF ANY NATURE, DIRECTLY OR INDIRECTLY, EXPRESS, STATUTORY OR IMPLIED, INCLUDING WITHOUT LIMITATION, MERCHANTABILITY OR FITNESS
FOR A PARTICULAR PURPOSE, SUITABILITY, DURABILITY, CONDITION, QUALITY OR ANY OTHER </FONT>CHARACTERISTIC&#9;OF&#9;THE&#9;PATENT&#9;RIGHTS,&#9;KNOW-HOW,&#9;MATERIALS&#9;<FONT STYLE="letter-spacing: -0.45pt">OR
</FONT>CONFIDENTIAL INFORMATION.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(b)</TD>
    <TD STYLE="text-align: justify">PATENT RIGHTS, KNOW-HOW, MATERIALS AND CONFIDENTIAL INFORMATION ARE PROVIDED &ldquo;AS IS,&rdquo;
AND COMPANY EXPRESSLY WAIVES ALL RIGHTS TO MAKE ANY CLAIM WHATSOEVER AGAINST OMRF FOR MISREPRESENTATION OR FOR BREACH OF PROMISE,
GUARANTEE, REPRESENTATION OR WARRANTY OF ANY KIND RELATING TO THE PATENT RIGHTS, KNOW-HOW, MATERIALS OR CONFIDENTIAL INFORMATION. OMRF
EXPRESSLY DISCLAIM ANY IMPLIED WARRANTIES ARISING FROM ANY COURSE OF DEALING, USAGE OR TRADE PRACTICE, WITH RESPECT TO: THE SCOPE, VALIDITY
OR ENFORCEABILITY OF THE PATENT RIGHTS, KNOW-HOW, MATERIALS AND CONFIDENTIAL INFORMATION; THAT ANY PATENT WILL ISSUE BASED UPON ANY PENDING
PATENT APPLICATION; OR THAT THE USE, SALE, OFFER FOR SALE OR IMPORTATION OF THE PATENT RIGHTS, KNOW-HOW OR MATERIALS WILL NOT INFRINGE
OTHER INTELLECTUAL PROPERTY RIGHTS. NOTHING IN THIS AGREEMENT WILL BE CONSTRUED AS AN OBLIGATION FOR OMRF TO BRING, PROSECUTE OR
DEFEND ACTIONS REGARDING THE PATENT RIGHTS, KNOW-HOW, MATERIALS AND CONFIDENTIAL INFORMATION.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(c)</TD>
    <TD STYLE="text-align: justify">COMPANY AGREES THAT OMRF AND ITS AFFILIATES WILL NOT BE LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY OR ARISING OUTOF ANY RIGHTS
GRANTED OR PERFORMANCE MADE UNDER THIS AGREEMENT, WHETHER TO OR BY COMPANY, SUBLICENSEE OR A THIRD PARTY. IN NO EVENT WILL
OMRF&rsquo;S LIABILITY OF ANY KIND INCLUDE ANY SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE LOSSES OR DAMAGES, EVEN
IF OMRF HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, OR EXCEED THE TOTAL AMOUNT OF ROYALTIES THAT HAVE ACTUALLY BEEN
PAID TO LICENSORS BY COMPANY AS OF THE DATE OF FILING AN ACTION AGAINST LICENSORS THAT RESULTS IN THE SETTLEMENT OR AWARD OF DAMAGES
TO COMPANY.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 6pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt">9.04</FONT></TD><TD>INDEMNIFICATION AND INSURANCE.</TD></TR></TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(a)</TD>
    <TD STYLE="text-align: justify">COMPANY will defend,
indemnify and hold harmless OMRF, OMRF&rsquo;s Affiliates and their respective trustees, officers, agents, independent contractors and
employees (&ldquo;OMRF&rsquo; Indemnitees&rdquo;) from any and all claims, actions, demands, judgments, losses, costs, expenses, damages
and liabilities (including attorneys&rsquo; fees, court costs and other expenses of litigation), regardless of the legal theory asserted,
arising out of or connected with: (i) the practice or exercise of any rights granted hereunder by or on behalf of COMPANY or any Sublicensee;
(ii) research, development, design, manufacture, distribution, use, sale, importation, exportation or other disposition of Licensed Products;
and (iii) any act or omission of COMPANY or any Sublicensee hereunder, including the negligence or willful misconduct thereof. OMRF and
OMRF&rsquo;s Affiliates shall have no obligation to indemnify COMPANY hereunder<B>. </B></TD></TR>
  </TABLE>
<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><B></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(b)</TD>
    <TD STYLE="text-align: justify">The Parties agree that this indemnity should be construed and applied in favor of maximum indemnification
of OMRF&rsquo;s Indemnitees.</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(c)</TD>
    <TD STYLE="text-align: justify">COMPANY will continuously carry occurrence-based liability insurance, including products liability
and contractual liability, in an amount and for a time period sufficient to cover the liability assumed by COMPANY hereunder during the
Term, and after. Prior to the date of the first human use of the first Licensed Product or the first commercial sale of the first commercial
Licensed Product, whichever is earlier, COMPANY shall obtain (and continuously maintain during the Term) occurrence-based liability insurance
coverage of at least FIVE MILLION (US $5,000,000). In addition, such policy will name OMRF and its Affiliates as additional-named
insureds. The minimum limits of any insurance coverage required herein shall not limit COMPANY&rsquo;s liability.</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B></B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 42pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">(d)</TD>
    <TD STYLE="text-align: justify">COMPANY expressly
waives any right of subrogation that it may have against OMRF Indemnitees resulting from any claim, demand, liability, judgment, settlement,
costs, fees (including attorneys&rsquo; fees) and expenses for which COMPANY is obligated to indemnify, defend and hold OMRF Indemnitees
harmless under this Agreement.</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 12pt; letter-spacing: -1.4pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt"><B>9.05
</B></FONT></TD>
    <TD STYLE="text-align: justify"><B>PROHIBITION AGAINST
INCONSISTENT STATEMENTS</B>. COMPANY shall not make any statements, representations or warranties, or accept any liabilities or responsibilities
whatsoever that are inconsistent with any disclaimer or limitation included in this section or any other provision of this Agreement.
COMPANY shall not settle any matter that will incur liability for OMRF or require OMRF to make any admission of liability without OMRF&rsquo;s
prior written consent on behalf of the OMRF.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center">Article 10.00 - Term and Termination</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><FONT><B>10.01
</B></FONT></TD>
    <TD STYLE="text-align: justify"><B>TERM</B>. This Agreement
will expire at the end of the Term. After expiration of this Agreement, COMPANY shall have a fully-paid up worldwide license</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>10.02</B></TD>
    <TD STYLE="text-align: justify"><B>TERMINATION FOR
BREACH. </B>If COMPANY commits a material breach of this Agreement, including without limitation, the failure to make any required royalty
or fee payments hereunder, OMRF will notify COMPANY in writing of such breach and COMPANY will have sixty (60) days after such notice
to cure such breach to OMRF&rsquo;s satisfaction. If COMPANY fails to cure such breach, OMRF may, at its sole option, convert any or all
exclusive licenses granted hereunder to non-exclusive licenses, or terminate this Agreement in whole or in part by sending COMPANY written
notice of termination.</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>10.03</B></TD>
    <TD STYLE="text-align: justify"><B>TERMINATION FOR
SUIT</B>. OMRF do not license to entities that bring suit against OMRF or its Affiliates, and as such, OMRF may immediately terminate
this Agreement if COMPANY or any Sublicensee directly or indirectly brings any action or proceeding against OMRF or its Affiliates, including,
but not limited to, challenging the validity of Patent Rights (whole or in part), except for an uncured material breach of this Agreement
by OMRF.</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>10.04</B></TD>
    <TD STYLE="text-align: justify"><B>TERMINATION BY COMPANY.
</B>COMPANY may terminate this Agreement at any time, in which case all rights in the Agreement will revert to OMRF, and COMPANY will
have (a) no further rights to manufacture, use, sell or otherwise commercialize any Licensed Product, including, but not limited to, the
ones that incorporate/use Know-How and/or Materials and (b) no further obligations to pay any royalties or milestone payments to OMRF.</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>10.05</B></TD>
    <TD STYLE="text-align: justify"><B>INSOLVENCY OF
COMPANY. </B>This Agreement terminates immediately without an obligation of notice of termination to COMPANY in the event COMPANY ceases
conducting business in the normal course, becomes insolvent or bankrupt, makes a general assignment for the benefit of creditors, admits
in writing its inability to pay its debts as they are due, permits the appointment of a receiver for its business or assets or avails
itself of or becomes subject to any proceeding under any statute of any governing authority relating to insolvency or the protection of
rights of creditors.</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.9pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.8pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.8pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>10.06</B></TD>
    <TD STYLE="text-align: justify"><B>SURVIVAL.</B> The
termination or expiration of this Agreement does not relieve either Party of its rights and obligations that have previously accrued.
After the Term, all rights granted immediately revert to OMRF. All Confidential Information of a Party shall be returned or destruction
certified, at the disclosing party&rsquo;s election. Rights and obligations that by their nature prescribe continuing rights and obligations
shall survive the termination or expiration of this Agreement including Sections 4.02 (Accounting), 6.06 (Third Party Litigation), 9.03
(Indemnification and Insurance), 10.6 (Survival) and Articles 7 (Name Use), 8 (Confidentiality) and 11 (General Provisions). COMPANY,
on behalf of itself and its Sublicensees, shall provide an accounting for and pay, within thirty (30) days of termination or expiration,
all amounts due hereunder.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.8pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 12pt Times New Roman, Times, Serif">Article 11.00 - General Provisions</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.01</B></TD>
    <TD STYLE="text-align: justify"><B>AMENDMENTS. </B>This
Agreement may not be amended or modified except by a writing signed by all Parties and identified as an amendment to this Agreement.</TD></TR>
  </TABLE>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.02</B></TD>
    <TD STYLE="text-align: justify"><B>CONSTRUCTION. </B>Parties
acknowledges that it was provided an opportunity to seek advice of counsel and as such this Agreement shall not be construed for or against
either Party.</TD></TR>
  </TABLE>

<P STYLE="font: bold 7pt Times New Roman, Times, Serif; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt"></TD>
    <TD STYLE="width: 36pt"><B>11.03</B></TD>
    <TD STYLE="text-align: justify"><B>ENTIRE AGREEMENT.
</B>This Agreement constitutes the final, complete and exclusive agreement between the Parties with respect to its subject matter and
supersedes all past and contemporaneous agreements, promises, and understandings, whether oral or written, between the Parties. This Agreement
may be executed in any number of counterparts which, when taken together, will constitute an original, and photocopy, facsimile, electronic
or other copies shall have the same effect for all purposes as an ink-signed original. Each Party hereto consents to be bound by photocopy
or facsimile signatures of such Party&rsquo;s representative hereto.</TD></TR>
  </TABLE>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; text-align: left"></P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.04</B></TD>
    <TD STYLE="text-align: justify"><B>EXPORT CONTROL.
</B>Parties agree not to use or otherwise export or re-export anything exchanged or transferred between them pursuant to this agreement
except as authorized by United States law and the laws of the jurisdiction in which it was obtained. In particular, but without limitation,
items exchanged may not be exported or re-exported (a) into any U.S. embargoed countries or (b) to anyone on the U.S. Treasury Department's
list of Specially Designated Nationals or the U.S. Department of Commerce Denied Person&rsquo;s List or Entity List. By entering into
this Agreement, Parties represents and warrants that they are not located in any such country or on any such list. Parties also agree
that they will not use any item exchanged for any purposes prohibited by United States law, including, without limitation, the development,
design, manufacture or production of missiles, or nuclear, chemical or biological weapons. In the event a Party becomes aware of any suspected
violations of this paragraph that Party will promptly inform the other of such suspected violation, and cooperate with one another in
any subsequent investigation and defense, be they civil or criminal.</TD></TR>
  </TABLE>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.05</B></TD>
    <TD STYLE="text-align: justify"><B>GOVERNING LAW
AND JURISDICTION.</B> This Agreement is made and performed in Oklahoma. The terms and conditions of this Agreement, as well as all disputes
arising under or relating to this Agreement, shall be governed by Oklahoma law, specifically excludingits choice- of-law principles, except
that the interpretation, validity and enforceability of the Patent Rights will be governed by the patent laws of the country in which
the patent application is pending or issued. This is not an Agreement for the sale of goods and as such Article 2 of the Uniform Commercial
Code does not apply. The exclusive forum for the foregoing are the state and federal courts of the State of Oklahoma. COMPANY agrees unconditionally
that it is personally subject to the jurisdiction of such courts.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.06</B></TD>
    <TD STYLE="text-align: justify"><B>HEADINGS. </B>The
headings of articles and sections used in this document are for convenience of reference only.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.07</B></TD>
    <TD STYLE="text-align: justify"><B>INDEPENDENT CONTRACTORS.
</B>It is mutually understood and agreed that the relationship between the Parties is that of independent contractors. No Party is the
agent, employee, or servant of the other. Except as specifically set forth here, no Party shall have nor exercise any control or direction
over the methods by which the other performs work or obligations under this Agreement. Further, nothing in this Agreement is intended
to create any partnership, joint venture, lease or equity relationship, expressly or by implication, between the Parties.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.08</B></TD>
    <TD STYLE="text-align: justify"><B>INDUCEMENT OF REFERRALS.
</B>It is not the purpose of this Agreement or the intent of the Parties to induce or encourage the referral of patients, and there is
no requirement under this Agreement or under any other Agreement between the Parties that COMPANY or its staff refer patients to OMRF
for products or services. No payment made under this Agreement is made in return for the referral of patients, or is made in return for
the purchasing, leasing, or ordering of any products or services.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.09</B></TD>
    <TD STYLE="text-align: justify"><B>LIMITATION OF RIGHTS
CREATED. </B>This Agreement is personal to the Parties and shall be binding on and inure to the sole benefit of the Parties and their
permitted successors and assigns and shall not be construed as conferring any rights to any third party. Specifically, no interests are
intended to be created for any customer, patient, research subjects, or other persons (or their relatives, heirs, dependents, or personal
representatives) by or upon whom the Licensed Products may be used.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.10</B></TD>
    <TD STYLE="text-align: justify"><B>NO ASSIGNMENT</B>.
Parties may not assign its rights hereunder to any third party without the prior written consent of the other Party; provided, that a
Party may assign its rights without the prior written consent of the other to any affiliate or other entity that controls, is controlled
by or is under common control with such Party. Any purported assignment in violation of this clause is void. Such written consent, if
given, shall not in any manner relieve the assignor from liability for the performance of this Agreement by its assignee.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 4.9pt 70.85pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt"><B>11.11</B></TD>
    <TD STYLE="text-align: justify"><B>NOTICES. </B>All
notices and other business communications between the Parties related to this Agreement shall be in writing, sent by certified mail, addressed
as follows:</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">To OMRF:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 269.05pt 0 78pt">Oklahoma Medical Research Foundation <U>Attn</U>: Director,
Technology Ventures</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 4.15pt 332.9pt 0 78pt">825 NE 13<FONT STYLE="font-size: 8pt">th </FONT>Street
Oklahoma City, OK 73104 Email: OTV@OMRF.ORG</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 4.5pt 0 0 76.5pt">To COMPANY:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 4.5pt 0 0 76.5pt"><FONT STYLE="font-weight: normal">JUPITER WELLNESS INC.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt">725 North Highway A1A Suite C106&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt">Jupiter,&nbsp;FL&nbsp;33477</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt">Email: rmiller@jupiterwellness.com</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">With a copy to (which notification shall not be deemed
notice):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">Lucosky Brookman LLP</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"><B>1</B>01 Wood Avenue South, 5th Floor</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">Woodbridge, NJ 08830</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">Email: jlucosky@lucbro.com</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify">Notices sent by certified mail shall
be deemed delivered on the third day following the date of mailing. Either Party may change its address or facsimile number by giving
written notice in compliance with this section.&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">11.12</TD>
    <TD STYLE="text-align: justify"><B>REGISTRATION OF
LICENSES. </B>COMPANY will register and give required notice concerning this Agreement, at its expense, in each country in the Territory
where an obligation under law exists to so register or give notice.</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">11.13</TD>
    <TD STYLE="text-align: justify"><B>SEVERABILITY. </B>In
the event any provision of this Agreement is held to be invalid or unenforceable, the remainder of this Agreement shall remain in full
force and effect as if the invalid or unenforceable provision had never been a part of the Agreement.</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6pt">&nbsp;</TD>
    <TD STYLE="width: 36pt">11.14</TD>
    <TD STYLE="text-align: justify"><B>WAIVER.</B> The
failure of a Party to complain of any default by the other Party or to enforce any of such Party&rsquo;s rights, no matter how long such
failure may continue, will not constitute a waiver of the Party&rsquo;s rights under this Agreement. The waiver by a Party of any breach
of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of the same or any other provision. No
part of this Agreement may be waived except by the further written agreement of the Parties.</TD></TR>
  </TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.85pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 70.8pt 0 6pt; text-align: justify; text-indent: 0in">&nbsp;&nbsp;</P>

<P STYLE="font: 11.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 70.85pt 0 6pt; text-align: justify"><B>IN WITNESS WHEREOF, </B>Parties
have executed this Agreement as of the Effective Date through the signatures of duly authorized persons.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 70.85pt 0 6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0.1pt 0 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 164.85pt 0 6pt"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 6pt"><B>OKLAHOMA MEDICAL RESEARCH</B></P>
</TD>
  <TD STYLE="width: 50%"><B>JUPITER WELLNESS</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By:<U>/s/ Adam Cohen</U></TD>
  <TD>By: <U>/s/ Brian S. John</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name: Adam Cohen</TD>
  <TD>Name: Brian S. John</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Title: Senior Vice President and General&#9;Counsel</TD>
  <TD>Title: CEO</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Date: June 16, 2021</TD>
  <TD>Date: June 16, 2021</TD></TR>
</TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 164.85pt 0 6pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 164.85pt 0 6pt"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 164.85pt 0 6pt"><B>&nbsp;</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99_1.htm
<DESCRIPTION>PRESS RELEASE, DATED JUNE 16, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Jupiter
Wellness Licenses Patents for the Treatment of Contact Dermatitis.</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>JUPITER,
FL / ACCESSWIRE /&nbsp;June, 17<SUP>th</SUP> 2021</B>&nbsp;/&nbsp;Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement
for two patents covering the use of Aspartame for the treatment of Contact Dermatitis.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">The
Licensing Agrement signed with the Oklahoma Medical Research Foundation covers the use of two issued patents, US 6,156,795, and US 6,326,400which
cover the use of aspartame for the treatment of contact dermatitis. Under the terms of the Agreement, Jupiter Wellness has the worldwide
exclusive license to utilize the Patent Rights, Know-How and Material related to N-L-Alpha-Aspartyl-L-Phenylalanine-1-Methyl Ester in
order to make, use, distribute, sublicense and sell Licensed Products or Licensed Services. Jupiter Wellness has separately filed an
additional patent for the use of a combination of CBD/aspartame for the treatment of a variety of skin conditions including atopic dermatitis
(eczema), published as US 20210038513.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">&ldquo;The
timely licensing of these patents gives us protection for the use of aspartame in commercial products that treat a range of skin conditions&rdquo;
stated Dr. Glynn Wilson, Chairman and Chief Scientific Officer of Jupiter Wellness. &ldquo;We will continue to expand our comprehensive
patent strategy to protect our consumer and Rx products.&rdquo;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Jupiter
Wellness had previously reported that in a double-blinded, placebo controlled clinical trial, JW-100, a novel topical formulation containing
CBD and aspartame, was shown to significantly reduce the ISGA score in 50% of atopic dermatitis patients after only two weeks of use.
The Company is currently preparing for a Pre-IND meeting with the FDA.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>About
Jupiter Wellness</B><BR> Jupiter Wellness, Inc. (NASDAQ:JUPW) is a leading developer of cannabidiol (CBD) based medical therapeutics
and wellness products. The Company&rsquo;s clinical pipeline of prescription CBD-enhanced skin care therapeutics address indications
including eczema, burns, herpes cold sores, and skin cancer. Jupiter generates revenues from a growing line of proprietary
over-the-counter skincare products including its flagship CaniSun&trade; sunscreen and other wellness brands sold through
www.cbdcaring.com. For additional information, please visit&nbsp;www.jupiterwellnessinc.com. The Company&rsquo;s public filings can
be found at&nbsp;www.Sec.gov.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 12pt Times New Roman, Times, Serif"><B>Safe
Harbor Statement</B><BR>
To the extent any statements contained in this presentation of Jupiter Wellness, Inc. (the &ldquo;Company&rdquo;) contains &ldquo;forward-looking
statements&rdquo; as defined in the Private Securities Litigation Reform Act of 1995 and the information that are based upon beliefs
of, and information currently available to, the company&rsquo;s management as well as estimates and assumptions made by the company&rsquo;s
management. These statements can be identified by the fact that they do not relate strictly to historic or current facts. When used in
this presentation the words &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; intend,&rdquo; believe,&rdquo; plan,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;projected&rdquo; and other words or the negative of these terms and similar expressions as they relate to the company or the company&rsquo;s
management identify forward-looking statements. Such statements reflect the current view of the company with respect to future events
and are subject to risks, uncertainties, assumptions and other factors relating to the company&rsquo;s industry, its operations and results
of operations and any businesses that may be acquired by the company. Should one or more of these risks or uncertainties materialize,
or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected,
intended, or planned. Although the company believes that the expectations reflected in the forward-looking statements are reasonable,
the company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security
laws of the United States, the company does not intend to update any of the forward-looking statements to conform these statements to
actual results.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">&nbsp;</FONT></P>

<P STYLE="font: 13.5pt Helvetica Neue; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Investor
&amp; Public Relations Contact Info</B><BR>
<FONT STYLE="background-color: white">Phone: 561-244-7100</FONT><BR>
<FONT STYLE="background-color: white">Email:&nbsp;</FONT><FONT STYLE="color: Blue">info@JupiterWellness.com</FONT></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>jupw-20210616.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /6ops7xRiXgOn8uMYnEsOaONqaOdzJV6aYkhs290fXl6HyIlgrf1+C41eIgWkeYK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:JUPW="http://jupiterwellness.com/20210616" elementFormDefault="qualified" targetNamespace="http://jupiterwellness.com/20210616">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://jupiterwellness.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="jupw-20210616_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="jupw-20210616_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="jupw-20210616_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="JUPW_WarrantsMember" name="WarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>jupw-20210616_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jupiterwellness.com/role/Cover" xlink:href="jupw-20210616.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://jupiterwellness.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliateCollateralizedSecurityLineItems" xlink:label="loc_srtAffiliateCollateralizedSecurityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="jupw-20210616.xsd#JUPW_WarrantsMember" xlink:label="loc_JUPWWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_JUPWWarrantsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName_50" xlink:type="arc" order="58" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>jupw-20210616_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="jupw-20210616.xsd#JUPW_WarrantsMember" xlink:label="JUPW_WarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JUPW_WarrantsMember" xlink:to="JUPW_WarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="JUPW_WarrantsMember_lbl" xml:lang="en-US">Warrants,</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliateCollateralizedSecurityLineItems" xlink:label="srt_AffiliateCollateralizedSecurityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AffiliateCollateralizedSecurityLineItems" xlink:to="srt_AffiliateCollateralizedSecurityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AffiliateCollateralizedSecurityLineItems_lbl" xml:lang="en-US">Affiliate, Collateralized Security [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>jupw-20210616_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jupiterwellness.com/role/Cover" xlink:href="jupw-20210616.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://jupiterwellness.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliateCollateralizedSecurityLineItems" xlink:label="loc_srtAffiliateCollateralizedSecurityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtAffiliateCollateralizedSecurityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="jupw-20210616.xsd#JUPW_WarrantsMember" xlink:label="loc_JUPWWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_JUPWWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtAffiliateCollateralizedSecurityLineItems" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>jupw8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:JUPW="http://jupiterwellness.com/20210616"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="jupw-20210616.xsd" xlink:type="simple"/>
    <context id="From2021-06-17to2021-06-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="From2021-06-162021-06-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="From2021-06-162021-06-16_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="From2021-06-162021-06-16_custom_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">JUPW:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-06-17to2021-06-17">0001760903</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-06-17to2021-06-17">false</dei:AmendmentFlag>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-06-17to2021-06-17">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-06-17to2021-06-17">false</dei:EntityExTransitionPeriod>
    <dei:WrittenCommunications contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0024">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0025">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0026">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-06-162021-06-16" id="xdx2ixbrl0027">false</dei:PreCommencementIssuerTenderOffer>
    <dei:DocumentType contextRef="From2021-06-17to2021-06-17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-06-17to2021-06-17">2021-06-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-06-17to2021-06-17">JUPITER WELLNESS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-06-162021-06-16">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-06-162021-06-16">001-39569</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-06-162021-06-16">83-2455880</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-06-162021-06-16">725 N. Hwy A1A</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-06-162021-06-16">Suite C-106 Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-06-162021-06-16">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-06-162021-06-16">33477</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-06-162021-06-16">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-06-162021-06-16">244-7100</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2021-06-162021-06-16">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:Security12bTitle contextRef="From2021-06-162021-06-16_us-gaap_CommonStockMember">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-06-162021-06-16_us-gaap_CommonStockMember">JUPW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-06-162021-06-16_us-gaap_CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-06-162021-06-16_custom_WarrantsMember">Warrants,</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-06-162021-06-16_custom_WarrantsMember">JUPWW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-06-162021-06-16_custom_WarrantsMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-06-17to2021-06-17">true</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139724989019992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 17, 2021</div></th>
<th class="th"><div>Jun. 16, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_AffiliateCollateralizedSecurityLineItems', window );"><strong>Affiliate, Collateralized Security [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 17,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">001-39569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">JUPITER WELLNESS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001760903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">83-2455880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">725 N. Hwy A1A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Suite C-106 Jupiter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">33477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">244-7100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_AffiliateCollateralizedSecurityLineItems', window );"><strong>Affiliate, Collateralized Security [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">JUPW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=JUPW_WarrantsMember', window );">Warrants,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_AffiliateCollateralizedSecurityLineItems', window );"><strong>Affiliate, Collateralized Security [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Warrants,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">JUPWW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_AffiliateCollateralizedSecurityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_AffiliateCollateralizedSecurityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=JUPW_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=JUPW_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" "K3-%2EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " "K3-%2!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *M,T5(H
MO(42[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( *M,T5*97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ JTS14NC)]_ $!0
M6A4  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( *M,T5*?H!OPL0(  .(,   -              "  4@-
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ JTS14I>*NQS     $P(   L
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64$L%!@     )  D /@(  )P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="jupw8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jupiterwellness.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="jupw8k.htm">jupw8k.htm</File>
    <File>ex10_1.htm</File>
    <File>ex99_1.htm</File>
    <File>jupw-20210616.xsd</File>
    <File>jupw-20210616_def.xml</File>
    <File>jupw-20210616_lab.xml</File>
    <File>jupw-20210616_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "jupw8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "jupw-20210616_def.xml"
     ]
    },
    "inline": {
     "local": [
      "jupw8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jupw-20210616_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jupw-20210616_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "jupw-20210616.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 66,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 8,
    "total": 8
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "JUPW",
   "nsuri": "http://jupiterwellness.com/20210616",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "jupw8k.htm",
      "contextRef": "From2021-06-17to2021-06-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://jupiterwellness.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "jupw8k.htm",
      "contextRef": "From2021-06-17to2021-06-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "JUPW_WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants,"
       }
      }
     },
     "localname": "WarrantsMember",
     "nsuri": "http://jupiterwellness.com/20210616",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_AffiliateCollateralizedSecurityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliate, Collateralized Security [Line Items]"
       }
      }
     },
     "localname": "AffiliateCollateralizedSecurityLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001264931-21-000078-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001264931-21-000078-xbrl.zip
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MT/[M:Y#!0YGT&&3[!=:C2G))D!12K#"3)T$N&)3@S]"[S+GCH 8-);$(<VQ
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MYXJ$9%SJ'9K,]2*Q$B[4SQ=N82%UBVR^QOY^^^RD!U*[CC=7*^Y&V?;CIL*
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MC .8]+V(.N7ZC$]KHB7&T8?0N'RTL</4)#2B%HX'BQQ)TM"P$*3B\5P1DN%
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ML@6("_W @"L",)BI; [=S#5CU-=,)V7;)$QU@W% _+G@]+[Y JI;KY_3-"[
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MV?S?,^$-G,_9":A>H)3BRC2=M0'^PF%4*ZU#7NA/P,P?FDV07 >?6[AJ1M;
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M;;]ZM;=]9Q,70OXKY-7^'_A_/XD?)@%?7U_[Y/V):%+E2@Z3<K5BZ1C^%R)
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MY/K$L%42)QSY\/1#^^!/$G.?>L='[_\_4$L#!!0    ( *M,T5)6><2J> D
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M9L8*GY(XMR1]CDO"S,0!EI&Q%X=D<^F55VY8I9%]><AL_CO!-I6XV\]G\/,
M*T^MBL1;RA;D52QA2VHW>%!'=T5XUJD_J/(C>#XZ;IT_WOO6 'XLT9]+Y]5L
M=<\!O/MT>GQ^=!;U>V].Q(88'QP<3287QV='8J,*[%VI*1);KT:33Z=[/AUM
M\*]XMODLM&?U3/MHP*QH(!N)8QT/Q9,/X\GA^%\[6.KB:22\2>1*2*U-J6-*
MA!190+;2<R'GEHBAW.\%="^-*&JTQV:!*/ ,0[YTQ& ?NT):+W-J>\'?V0O_
M^?)\B]F.C?Z/X'.>4K]WTA9OC.*%U#LLB,(NE4]#43Y>9C*%1?&>$G1K)L[(
MD;1Q*MX  PE*8W157[=>7:Z^<JZ$J1H$D?@T$2^CK>V7T:O7VQ% E%17GC][
M&;W8W%RF*D[[O6!JW9+\:YS$-4Z2#B?BDTYJ&T!T[H(_.!DW (W$3;2+5%;N
M+XW-DJ5*D!RZBK/2J075&(<U(TJO,F0Q/%MQN3CC^8?P_JG-<O#6+$-D[W'/
M*J3+4H;#A-_],#@9C+,BE8,*^ZL,%TY3TJM,9E(K38.MP7ORZ2H31X[=4[K?
M,S8$8X"-2S0SLA*)1#EOU;3T.';EM/&/%W:(J!DWB3BU)BEC="!2UUX$)!8X
M1J)N38,C. >?LY68J8R;'%[()%%<:D14U;.M1E,F5"*?*ET!@AMX_W#CCMI)
ML9!6D5_QB;M4#"1=K>,0.]*?!&+QIE#Q6H7[O2<4_T&Y!",5'+Y+V4W'>&)R
MV]Q\_LOVUO.?A'&?A/$X2WXOS6[@#8]' 8^.^ZL. Q(:QI^C;QRP(0IK/,4!
M%#<1TX(C%#[/R<;<,46#69]*7P$&2+%2S^D6G#RVP:U^S_G09X=V*'[-5EJ+
M"Y4Y@[@.4JF '!W:XR!5-!.36,%+-0.J/L[P/UH EF]VPU#4,5^ %Q3:BKE&
MZ3(0 5T5;,^4EGTO+*6<B@624_<'.A0'\Q4_7">A?EJ[$K$&=\ZNVG"'=20_
M07N/H/U2B:<2$\G20IG2 <*6"F,#/S/8@"PI$@-*H0%H!6,D <-D,J:I"=6W
M)F-&C'$O#$//'(]Q<C$ Z6"F"8WQA<M,6+@-Q.=EULQ(#"J\IN?]'K@QE+]M
M@4@LF7E3L]2,%Q["C$ZI?? 1 *E&SO'DU[%PL;&A:;8W_Q8:Z28_<A>JT(9R
MQH V&E9X(B^)+L,X1 L.^SWT,G16#B"O,*Q%7%I+844D"(YQ8W//2HP1&AQ_
M.!0Y0;+C:JL.WAR.?[+L/:OZ\=24T- WV2AL4/;/]KZ@J=N4.I<3VIQD&* )
M 92FJ%@.H-)RJA)E,O$$0'PJII)505[K.Y35RH(@=&(,6D;ILNF=EJK$&G(>
M6\>TY;JF*%1!. YL#22YV*HBM !6&Y!.9=@Z5#PN+5U;44!H6%X+S0=C@>+[
MO4X+5',_$M/2:D2.-POB_44&@^@*5^G*VC;6L9W(F9,FIF2'AEH0:!R[<&MR
MY&ENS9*-=TZ;@G6)M"OH+^C1 5P<Q-"[;(>-![_;0=6YIWAKG\FY2U6!O:Y6
MDU(_QB!(:!="32,51-4@,AQUE]HIYEL"!N! ?&I-.8<67BZ7PWB:Q*$5AQ@S
M0XAN*]:TF-),,2%-3%2$2HJ%<LI7T&<#GZOPFY7@:V7IMA(&,16S[,."CC/8
M[TU9O)5,5FM&)Q0/YV;Q3;T_KCCR[@W_5,:7* 760JXS8W<$]@2>'JK];^GD
MJB&_DQ-^V#_T^D3.H!C>2CM%72>L8%@;-ZT.AC:!9N$I2PKF:=<\Y)J)@EX"
MVGW*O(\.P*U6@W^-*MAFK6U:"(2SIXU1U]P'OI;2)H/,F,LPNSH'ZG=8>"<T
MZQS!SLBJ!9Y"H)@IP"KQ%S"OYI5C9\2@%>,X; *V7K_>#AW!+Z[AN9K(W&<5
M/Y4%KDU!+#0#(YA9U>GK+W3S2RZDRB2F.(9I% S'-Y".<LAYM>.%^]P<_$M
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MN8S6] PO[2H2AQ3"S?9CVB>M.)PPL]PUC@63(0_L996_\-FL2+A#0UO.[DJ
M#WNM,"/\33;U!IUSK>SWNO^XUP\FW[3[>#[<AG^M.(+]DA[((>B-8PV,@C=
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MUZNXU@H>]7?9<O/#_!]?>LG_ %!+ P04    " "K3-%2/@<*;AP,   ]D@
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M?R'/8+U:.K=, #:;4!BB@*BP.P.P*,5(J9&0>P'CAB=KS)_G2=0S5+2%;M&
MC#;9,%4!P0%8 ^@HU6A^,?,YDMSB[44L0$V62?&<7 \EH-XM+#VVF\P XH#0
MZ78($"2"4#/*)T@7:<3X ZO=[C!C&]$!/L]8#,]0>J+<0C6H"DVT.D," FR(
M3P"S1NA><4\*8O+I9E4 DB5X(>XTCL6.RLH_ETE*IF#]K5JW='78;3)E$09$
M$NP.X*=4[ND/2,:@ZS04: Y?4-5#_] <#H7F,&AH#E\#S>T3"P2:HQ=4]<@_
M-$=#H3D*&IJC5T$C&MYK7S,3'Z_Y+7NRW9P-*KT@T[9J!68G"P^7EK<^6&2
MG,_($)^8J(G5-;_A[#%)(WC*#,F]  .8ME)C:,-#QVZPCY]J0JSCO/8UQ:2\
M]TNB97YZF:9)>Q=3:,*#I&FLMW,IU#Z1N&%9CNF_DX?. W&[V L>5L-62!K*
M\%"QV>L#IHA!(LC'@76)J[R@87V4S%CO[&JSS59UB;F^,@@(;([:R2B*LR>%
MR'4S2T8YP4"/T%SMK)$MIJHVKJT+HXG;AEHMK+[70N/CBRRSWM&;.Y;"-PBT
M):Y:&C*G6]M<'T2+ Z;,5E<RI'2>SL;+S%N9O?NNK7,VLIMVJH%<KPBB=4TW
MK6%:KW?<FE]XDHLMR]1%F[2\RF.[;Q#0N6KE3INZQ:VB(%J_RUDKS5"A14VQ
M8RSFC"91DB?IZH/,+9)@6ZUL(E= P 8U#6U%$"B MEKYA2HATDK'$-QP(B$D
MHB'40X RX2*_7BZMHWV7V!44_88U'+ R"$AZ[9FPB(!Q5(M 10A2,7ZQN<BR
M#>$O@L<2X@DAT#P 4DL?(DZ0R5ZHBD"?;.GL5M/#Q6V2M[+>V27.QB3 7#4B
M&>N#8 ,P9;*@ULDLJ-/#/R_^4F49<]S\5^R68YE2?_Z\7C *9)^RJEQ!T&%1
M<V"1!($"[,NDX8JA4HH*K8_L5 VSENH8ZUT!8+6EF[ZQ,HA&MSEJ??D;;>VI
MRS_;1G?"% $>2+#+7'?]-I-F]U_7!(% A['608G.+JFU/AY(V U9J_Y)P,K;
M)&#5,PE8A3@)6 V=!*R\30+T9HL4(:)?NE[09(6!Y(2=:M=0=%@V^;!(@T(%
M]@?V&54(VL6XSFBI4IS)UQ;QM=K^N?A@J26@<Y;3LLMFE=32)@J"D2YGK;26
M1=*YFAA)M6LN-G&2D[@P<YZD.(T23*OTB+8SXOTASF@9:+X"IT<?!D/#3+9P
M*L)T+L,J<)?JTO6I].(&C"^$TE]2]I3."<Y82N+B7(KM2E&WWNT=,SVVFS?-
M .(@<!KB$+AU1@:-[V44TF'EF3 O)'UF=)/FF*MGR;FM9P)T;LD!;#:),40!
MD6)W!A!2B5&A]O. =I$]HIID%>]C!"L(R1T_KMUIVGAJVZH-B)E.@] SW&7.
MC]W<N(CR](BE?(]$E">/Y#W.<>D-K"\D=_U099=I\VE*FS8@A#H-@L]/5C$R
M50S63'E+&<-G8JJU8AUWB1LJ]XEC6A;;N6,J24!XV'QU9)#A2&N]L#!?8TK?
M;;(D)1D\$!DJMRQ8+399:$@"8L'F"V!!29'6>F'A;$WX2@QO/W/VE-^5^5G!
MN@%JMVQT6FXR8I4&Q$J7/X 9'8**&)U2UP\\VUU"\2++(EQ3B]0Q-J!9@YF6
M+B1@(',M6BB)Y/F6*Y:C6X8^903E=P2=E:_GK6>"+\KQ]::1*)(/1!2S\C3&
MW(90E]CY6T= PZUWC[2408#4:P]^#TD5@72(8VJN!<.\?ARG3,AWZ8%/._2'
MN")HJ'G-49\^")H&FC294F'-@VL5J-Z+Z#.;43VY/3S%:X@<SXPM!HV)<4T1
M!".@+6A:7']7@)_<>9L%3:)SRC!\EJ6A<9PQKVW/2):W$P1$0-L5E")/"9%2
M>FG_=SB]YYN'/'J^X2PB1-YEE56]5=_YMX'1;IEY496:- T*#8BSE_@%"-P5
M@6IE[-5&+)\G\VHOOI_?8;$#KS=Y)D=080P^"]X9Y/CRPH *&!<9.B("0F^
M3>B"@XI$*G0/%<&H%NWI^"S;90$D\;OGCV1)N'SNX)9L\W=B0_<=1Q@#8ET?
MO0VNCGDPUQL8!(0O=0L=ZF6H7@!:R'O$RB+05UD(4J6X?G^YOA;3N'^)\$NR
MPO2:%]FXA<NX,S?ZT'#75\M>4BGSZMF0V"  ?85A\.I:5<8>*DI!JAB9D6E7
M$'0?='W1I?@D%NM%XM<"9T0L^1]02P,$%     @ JTS14HR<FCY\"   [V@
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MT)XF30^[@-8 Y1CF%,)^.M6@?-6I1*U;?="?%I^87^;_T^@C_P!02P,$%
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M'NK4S]N=WO>5IU<AZ-RQF -[-[(-&*3PE &2T\BPD)S=4_>1,4#VB/ FQX+
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MG$.H$#]% ZJ!4NWN4 8J9O.J*)4GGQD=.YJ-=6(X3)LA!@O/!C,QU!V!C#Y
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ML>NIH.BFN#L(FQ+!C'"+JH,GK_B^^JH5"FXLYV)LQQWK;S$)5 %K8<YO?X0
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M2[]84S6]]W=Z^B%MSBZ:O;-*/O.N_?XS^W1Q?.RR]/\!4$L! A0#%     @
MJTS14BR]4CAG3   =+(!  H              ( !     &5X,3!?,2YH=&U0
M2P$"% ,4    " "K3-%25GG$JG@)   N'P  "@              @ &/3
M97@Y.5\Q+FAT;5!+ 0(4 Q0    ( *M,T5+5NS)JJ ,  -0-   1
M      "  2]6  !J=7!W+3(P,C$P-C$V+GAS9%!+ 0(4 Q0    ( *M,T5)N
M$UP-*PD  %YN   5              "  09:  !J=7!W+3(P,C$P-C$V7V1E
M9BYX;6Q02P$"% ,4    " "K3-%2/@<*;AP,   ]D@  %0
M@ %D8P  :G5P=RTR,#(Q,#8Q-E]L86(N>&UL4$L! A0#%     @ JTS14HR<
MFCY\"   [V@  !4              ( !LV\  &IU<'<M,C R,3 V,39?<')E
M+GAM;%!+ 0(4 Q0    ( *M,T5+=L+OD)A8  (5\   *              "
E 6)X  !J=7!W.&LN:'1M4$L%!@     '  < L $  +".      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
